AURICCHIO, SALVATORE
 Distribuzione geografica
Continente #
AS - Asia 3.840
NA - Nord America 3.507
EU - Europa 2.726
SA - Sud America 499
AF - Africa 86
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.666
Nazione #
US - Stati Uniti d'America 3.358
SG - Singapore 1.799
RU - Federazione Russa 1.212
VN - Vietnam 730
CN - Cina 660
BR - Brasile 394
DE - Germania 328
HK - Hong Kong 314
IT - Italia 297
UA - Ucraina 214
FI - Finlandia 196
FR - Francia 141
GB - Regno Unito 99
CA - Canada 93
IE - Irlanda 64
IN - India 55
NL - Olanda 46
BD - Bangladesh 40
AR - Argentina 38
JP - Giappone 35
MX - Messico 34
KR - Corea 30
IQ - Iraq 26
PL - Polonia 26
ZA - Sudafrica 26
TR - Turchia 22
SE - Svezia 20
PH - Filippine 19
CI - Costa d'Avorio 17
LT - Lituania 17
TH - Thailandia 17
ES - Italia 15
PK - Pakistan 15
CZ - Repubblica Ceca 13
EC - Ecuador 13
ID - Indonesia 13
CO - Colombia 11
MA - Marocco 10
UY - Uruguay 10
AT - Austria 8
PE - Perù 8
PY - Paraguay 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
IL - Israele 7
JM - Giamaica 7
UZ - Uzbekistan 7
KH - Cambogia 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
CH - Svizzera 4
CL - Cile 4
IR - Iran 4
KE - Kenya 4
OM - Oman 4
TW - Taiwan 4
BE - Belgio 3
BO - Bolivia 3
DZ - Algeria 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
RO - Romania 3
AD - Andorra 2
AM - Armenia 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
BG - Bulgaria 2
BJ - Benin 2
ET - Etiopia 2
GE - Georgia 2
GF - Guiana Francese 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
MK - Macedonia 2
VC - Saint Vincent e Grenadine 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GN - Guinea 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
Totale 10.649
Città #
Singapore 875
San Jose 520
Chandler 337
Moscow 313
Hong Kong 306
Ashburn 271
Jacksonville 225
Ho Chi Minh City 223
Beijing 217
Munich 163
Santa Clara 159
Hanoi 146
Los Angeles 105
Lauterbourg 95
Princeton 91
Millbury 85
The Dalles 84
Helsinki 79
Nanjing 67
Naples 64
Hefei 62
Wilmington 52
Dallas 50
Napoli 48
New York 47
Boston 42
Ottawa 40
Haiphong 38
Buffalo 36
Amsterdam 34
Da Nang 30
Tokyo 29
São Paulo 26
Montreal 25
Orem 25
Redondo Beach 24
Brooklyn 21
Nanchang 21
Warsaw 20
Denver 19
Atlanta 17
Chennai 16
London 16
Manchester 16
Rome 15
Seattle 15
Frankfurt am Main 14
San Francisco 14
Turku 14
Johannesburg 13
Phoenix 13
Poplar 13
Seoul 13
Biên Hòa 12
Boardman 12
Hebei 12
Houston 12
Kronberg 12
Mexico City 12
Norwalk 12
Shenyang 12
Chicago 11
Des Moines 11
Falkenstein 11
Milan 11
Nuremberg 11
Can Tho 10
Hải Dương 10
Jiaxing 10
Mumbai 10
Porto Alegre 10
Rio de Janeiro 10
Thái Bình 10
Tianjin 10
Baghdad 9
Brno 9
Falls Church 9
Hanover 9
Toronto 9
Belo Horizonte 8
Brasília 8
Changsha 8
Montevideo 8
Orange 8
Quảng Ngãi 8
Council Bluffs 7
Jyväskylä 7
Querétaro 7
Salerno 7
Thái Nguyên 7
Agropoli 6
Bangkok 6
Ipatinga 6
Lawrence 6
Pelotas 6
Queens 6
Secaucus 6
Shanghai 6
Stockholm 6
Charlotte 5
Totale 5.721
Nome #
Gluten consumption and inflammation affect the development of celiac disease in at-risk children 278
Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten. 173
A Celiac Cellular Phenotype, with Altered LPP Sub-Cellular Distribution, Is Inducible in Controls by the Toxic Gliadin Peptide P31-43. 158
Author Correction: Gluten consumption and inflammation affect the development of celiac disease in at-risk children 155
Inflammation Is Present, Persistent and More Sensitive to Proinflammatory Triggers in Celiac Disease Enterocytes 154
CELL SHAPE DISCRIMINATES BETWEEN NORMAL AND CELIAC DISEASE (CD) DENDRITIC CELLS (DC). 144
Gliadin peptide P31-43 localizes to endocytic vesicles and interferes with their maturation. 144
Pediatric celiac disease patients show alterations of dendritic cell shape and actin rearrangement 144
Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 143
Immunogenicity of monococcum wheat in celiac patients 142
The toxic alpha-gliadin peptide 31–43 enters cells without a surface membrane receptor 141
GLIADIN PEPTIDE P31-43 PRESENTS IL15 IN TRANS TO THE NEIGHBOURING CELLS 140
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. 139
Clinical, HLA and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. 137
M.V. Barone, M. Nanayakkara, D. Zanzi, S. Santagata, G. Lania, V. Discepolo, M. Ten-Eikelder, S. Auricchio 136
Potential celiac patients: a model of celiac disease pathogenesis. 136
Gliadin peptide P31-43 interferes Hrs (hepatocyte growth factor-regulated tyrosine kinasesubstrate) localization to endocytic vesicles: implications for Celiac Disease (CD) 134
Gliadin peptide P31-43 interferes with Hrs localization to endocytic vesicles 133
An undigested gliadin peptide activates innate immunity and proliferative signalling in enterocytes: the role in celiac disease 133
Antibody Profile, Gene Expression and Serum Cytokines in At-Risk Infants before the Onset of Celiac Disease 132
Celiac disease patients dendritic cells have a different shape when interacting with the substrate compared to controls. 132
Susceptibility to deamidation by tissue transglutaminase as a tool to identify immunogenic gliadin peptides in the whole gliadin extracts 130
Adaptive and innate immune responses in celiac disease. 129
Interleukin-10 downregulates inflammation in the small intestinal mucosa of patients with potential celiac disease. 129
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease 128
Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals 126
Both innate immunity and growth factor receptor (EGFR) contribute to P31-43 induced proliferation effects in CACO2 cells and celiac enterocytes. 125
Gliadin activates HLA class I-restricted CD8+ cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. 124
Constitutive alterations in vesicular trafficking increase the sensitivity of cells from celiac disease patients to gliadin 124
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 123
AN IMMUNODOMINANT DQ8 RESTRICTED GLIADIN PEPTIDE ACTIVATES SMALL INTESTINAL IMMUNE RESPONSE IN "IN VITRO" CULTURED MUCOSA FROM HLA-DQ8 POSITIVE BUT NOT HLA-DQ8 NEGATIVE CELIAC PATIENTS. 122
Safety for Patients With Celiac Disease of Baked Goods Made of Wheat Flour Hydrolyzed During Food Processing 122
Altered trafficking of EGF in endocytic proliferation and innate immunity markers in MARSH 0 (M0) biopsies of celiac patients. 121
P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: A role in celiac disease 120
Flow cytometric and immunohistochemical analysis reveal an increase of CD4+ CD25+ FOXP3+ regulatory T cells in the small intestinal mucosa of potential and untreated coeliac patients. 119
In Celiac Disease Patients the In Vivo Challenge with the Diploid Triticum monococcum Elicits a Reduced Immune Response Compared to Hexaploid Wheat 118
Gliadin-Specific CD8(+) T Cell Responses Restricted by HLA Class I A*0101 and B*0801 Molecules in Celiac Disease Patients 117
Blockage of T-cell costimulation inhibits T-cell action in celiac disease 115
GLIADIN P31-43 PEPTIDE CAN DELAY EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR) DECAY INTERIFERING WITH THE ENDOCYTIC PATHWAY 112
Pivotal Role of Inflammation in Celiac Disease 111
Lactobacillus paracasei CBA-L74 and its postbiotic inhibit endocytosis in Caco-2 cells 110
Enzymaticactivity hydrolyzing -glutamyl- -naphthylamide in human intestine during adultand fetal life 110
Identification of immunodominant epitopes of {alpha}- gliadin in HLA-DQ8 transgenic mice following oral immunization. 109
Brush border and cytosol peptidase activities of human small intestine in normal subjects and celiac patients. 107
Amines Protect Invitro the Celiac Small-intestine From the Damaging Activity of Gliadin Peptides 107
Gliadin-specific type 1 regulatory T-cells from the intestinal mucosa of treated coeliac patients inhibit pathogenic T-cells. 104
celiac disease assocition with CD8+ T cell responses: identification of a novel gliadin-derived hla-a2 restricted epitope. 103
PTPRK, an EGFR Phosphatase, Is Decreased in CeD Biopsies and Intestinal Organoids 103
Gliadin regulates the NK-dendritic cross-talk by HLA-E surface stabilization 102
Gluten sensitivy in a subset of children with insuli-dependent diabetes mellitus. 102
FOXP3+ regulatory T-cells are increased in the untreated celiac mucosa and are expanded by gliadin in the in vitro cultured treated mucosa. 101
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 epithelial cells. 101
EVIDENCE OF CHRONIC INFLAMMATION IN MORPHOLOGICALLY NORMAL SMALL INTESTINE OF CYSTIC FIBROSIS PATIENTS. 100
Production of antiendomysial antibodies after in vitro gliadin challenge of small intestinal biopsy samples from patients with coeliac disease 100
Recombinant human IL-10 suppreses gliadin-dependent T-cell activation in ex vivo cultured celiac intestinal mucosa. 100
ANTI TISSUE TRANSGLUTAMINASE ANTIBODIES FROM COELIAC PATIENTS INHIBIT TRANSGLUTAMINASE ACTIVITY BOTH IN VITRO AND IN SITU. 99
In siblings of coeliac children rectal gluten challenge reveals sensitisation to gluten not restricted to coeliac HLA 96
Interleukin 15 mediated epithelial changes in celiac disease 96
Arylamidase activities of brushborder membrane of rat intestine 95
Celiac disease: role of intestinal compartments in the mucosal immune response. 95
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. 94
Second ESPGHAN Capri Meeting: “Genetic factors in functional and structural gastrointestinal disorders”. 91
Rotavirus and celiac disease: clues to the pathogenesis and perspectives on prevention. 90
FAS engagement drives apostosis of enterocytes of coeliac patients 89
ZONULA OCCLUDENS TOXIN (ZOT) INTERFERES WITH THE INDUCION OF NASAL TOLERANCE TO GLIADIN. 89
Transglutaminase 2 in coeliac disease. 84
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide 31-43 uptake by epithelial cells. 82
Chapter 8. 50 Years of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): Captivating Witness Reports of a Success Story 80
INTRANASAL ADMINISTRATION OF ONE ALPHA GLIADIN CAN DOWNREGULATE THE IMMUNE RESPONSE TO WHOLE GLIADIN IN MICE. 79
Characterization of the anti-tissue transglutaminase antibody response in non-obese diabetic mice. 78
Laser capture microdissection as a tool to study the mucosal immune response in celiac disease 78
Gliadin activates mucosal cell-mediated immunity in in vitro cultured rectal mucosa from coeliac patients and a subset of their siblings 77
SERUM IMMUNOGLOBULINS A AND G, AND MONOCLONAL ANTIBODIES ANTI TISSUE TRANSGLUTAMINASE FROM COELIAC PATIENTS INHIBIT THE CATALYTIC ACTIVITY BOTH IN VITRO AND IN SITU 77
Adjuvant effect of lactobacillus casei in a mouse model of gluten sensitivity. 77
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells. 77
Alpha-Glutamyl-beta-naphthylamide hydrolase of rabbit small intestine. Localization in the brush border and separation fromother brush border peptidases. 76
Low risk of colon cancer in patients with celiac disease 76
Automic dysfunction in children with hirschsprung's disease. 75
Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat. 73
Terapia del reflusso gastroesofageo 73
Dietary proteins and mechanisms of gastrointestinal diseases: gliadin as a model. 73
Evidence for still ongoing convergence evolution of the lactase persistence T -13910 alleles in humans. 72
Intravenous or intranasal administrtion of gliadin is able to down-regulate the specific immune response in mice. 71
EXPRESSION AND ENZYMATIC ACTIVITY OF TRANSGLUTAMINASE IN THE NORMAL AND COELIAC DISEASE 71
Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of coeliac patients 68
In mice, intravenous or intranasal administration of gliadin is able to down-regulate the specific autoimmune response 68
Colite ulcerosa e colite allergica 67
Gliadin peptide P31-43 presents in trans IL15. 65
INTERLEUKIN 18 ASSOCIATED MARKERS OF T HELPER CELL TYPE 1 ACTIVITY IN COELIAC DISEASE. 64
Enhanced expression of interferon regulatory factor-1 in the mucosa children with coeliac disease. 63
Possible drug targets for coeliac disease. 63
Dietary proteins and mechanism of gastrointestinal disease: gliadin as a model. 61
IL-15 drives the specific migration of CD94+ and TCR-gamma delta+ intraepithelial lymphocites in organ cultures of treated celiac patients 61
Correction of Gliadin Transport Within Enterocytes Through Celiac Disease Serum 61
Identification of immunodominant epitopes of (alpha)-gliadin in HLA-DQ8 transgenic mice following oral immunization. 60
Sourdough Bread Made from Wheat and Nontoxic Flours and Started with Selected Lactobacilli Is Tolerated in Celiac Sprue Patients. 59
Primo incontro regionale di gastroenterologia pediatrica 59
Bayesian Sequential Pragmatic Cluster Randomized Clinical Trial Design for PrEventive Effect of MEditerranean Diet in Children: PEMED Trial Research Protocol 58
Esophageal motor involvement in minimal change myopathy. 58
Dolore addominale ricorrente ed infezione da Helicobacter pylori: un esempio di revisione critica delle conoscenze 57
Totale 10.377
Categoria #
all - tutte 34.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.665


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022488 7 0 0 3 6 22 8 12 74 35 138 183
2022/2023694 105 86 27 48 85 80 3 77 117 29 24 13
2023/2024441 20 68 54 26 18 11 6 90 17 4 95 32
2024/20252.946 171 208 17 9 93 150 347 236 213 291 959 252
2025/20265.113 588 338 541 537 996 180 534 299 700 263 99 38
Totale 10.815